drugset / Trial / NCT01749085

Study To Determine The Effect Of Food And Strong CYP3A4 Enzyme Inhibitor On PF-04449913 Drug Levels

NCT01749085

Phase 1 Completed 14 enrolled Pfizer
Non-randomizedCrossoverOpen-labelBasic science

Summary

The study aims to determine what effect a high fat meal will have on the drug exposure of PF-04449913. The study also aims to determine the effect of a strong enzyme (CYP3A4) inhibitor on drug exposure of PF-04449913.

Timeline

Start
2012-12
Primary completion
2013-02
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Glasdegib Small molecule 200 mg Oral
Background Ketoconazole Small molecule

Indications

No indication recorded.